» Articles » PMID: 38989934

Cholesterol Metabolism: Physiological Versus Pathological Aspects in Intracerebral Hemorrhage

Overview
Date 2024 Jul 11
PMID 38989934
Authors
Affiliations
Soon will be listed here.
Abstract

Cholesterol is an important component of plasma membranes and participates in many basic life functions, such as the maintenance of cell membrane stability, the synthesis of steroid hormones, and myelination. Cholesterol plays a key role in the establishment and maintenance of the central nervous system. The brain contains 20% of the whole body's cholesterol, 80% of which is located within myelin. A huge number of processes (e.g., the sterol regulatory element-binding protein pathway and liver X receptor pathway) participate in the regulation of cholesterol metabolism in the brain via mechanisms that include cholesterol biosynthesis, intracellular transport, and efflux. Certain brain injuries or diseases involving crosstalk among the processes above can affect normal cholesterol metabolism to induce detrimental consequences. Therefore, we hypothesized that cholesterol-related molecules and pathways can serve as therapeutic targets for central nervous system diseases. Intracerebral hemorrhage is the most severe hemorrhagic stroke subtype, with high mortality and morbidity. Historical cholesterol levels are associated with the risk of intracerebral hemorrhage. Moreover, secondary pathological changes after intracerebral hemorrhage are associated with cholesterol metabolism dysregulation, such as neuroinflammation, demyelination, and multiple types of programmed cell death. Intracellular cholesterol accumulation in the brain has been found after intracerebral hemorrhage. In this paper, we review normal cholesterol metabolism in the central nervous system, the mechanisms known to participate in the disturbance of cholesterol metabolism after intracerebral hemorrhage, and the links between cholesterol metabolism and cell death. We also review several possible and constructive therapeutic targets identified based on cholesterol metabolism to provide cholesterol-based perspectives and a reference for those interested in the treatment of intracerebral hemorrhage.

References
1.
Chen L, Ma M, Sun M, Jiang L, Zhao X, Fang X . Endogenous sterol intermediates of the mevalonate pathway regulate HMGCR degradation and SREBP-2 processing. J Lipid Res. 2019; 60(10):1765-1775. PMC: 6795084. DOI: 10.1194/jlr.RA119000201. View

2.
Sun R, Peng M, Xu P, Huang F, Xie Y, Li J . Low-density lipoprotein receptor (LDLR) regulates NLRP3-mediated neuronal pyroptosis following cerebral ischemia/reperfusion injury. J Neuroinflammation. 2020; 17(1):330. PMC: 7643474. DOI: 10.1186/s12974-020-01988-x. View

3.
Magid-Bernstein J, Girard R, Polster S, Srinath A, Romanos S, Awad I . Cerebral Hemorrhage: Pathophysiology, Treatment, and Future Directions. Circ Res. 2022; 130(8):1204-1229. PMC: 10032582. DOI: 10.1161/CIRCRESAHA.121.319949. View

4.
Cainelli E, Arrigoni F, Vedovelli L . White matter injury and neurodevelopmental disabilities: A cross-disease (dis)connection. Prog Neurobiol. 2020; 193:101845. DOI: 10.1016/j.pneurobio.2020.101845. View

5.
Ogura M . PCSK9 inhibition in the management of familial hypercholesterolemia. J Cardiol. 2017; 71(1):1-7. DOI: 10.1016/j.jjcc.2017.07.002. View